• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 69-83 of 318 results

1003 Exhibit: Serial No 11083,167, Declaration Under 37 CFR 1132 of Elliot Ehrich ...

Document IPR2018-00943, No. 1003-3 Exhibit - Serial No 11083,167, Declaration Under 37 CFR 1132 of Elliot Ehrich undated (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1038 Exhibit: Synopsis, Naltrexone HC1, ALZA Corporation

Document IPR2018-00943, No. 1038-33 Exhibit - Synopsis, Naltrexone HC1, ALZA Corporation (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1044 Exhibit: Bertil Abrahamsson and Anna Lena Ungell, Biopharmaceutical suppo...

Document IPR2018-00943, No. 1044-39 Exhibit - Bertil Abrahamsson and Anna Lena Ungell, Biopharmaceutical support in formulation development (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1011 Exhibit: Henry R Kranzler et al, Sustained Release Naltrexone for Alcoholism ...

Document IPR2018-00943, No. 1011-58 Exhibit - Henry R Kranzler et al, Sustained Release Naltrexone for Alcoholism Treatment A Preliminary Study (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1059 Exhibit: WayBack Machine capture of Security and Exchange Commissions In...

Document IPR2018-00943, No. 1059-61 Exhibit - WayBack Machine capture of Security and Exchange Commissions Information Page regarding the Electronic Data Gathering, Analysis, and Retrieval Sys...

cite Cite Document

1014 Exhibit: US Patent No 7,157,102

Document IPR2018-00943, No. 1014-14 Exhibit - US Patent No 7,157,102 (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1023 Exhibit: ReVia, Physicians Desk Reference 936 938 53rd ed 1999

Document IPR2018-00943, No. 1023-21 Exhibit - ReVia, Physicians Desk Reference 936 938 53rd ed 1999 (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1028 Exhibit: Rubio, et al, Naltrexone versus acamprosate one year follow up of alc...

Document IPR2018-00943, No. 1028-59 Exhibit - Rubio, et al, Naltrexone versus acamprosate one year follow up of alcohol dependence treatment (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1040 Exhibit: TREXAN, Physicians Desk Reference 936 938 46 ed 1992

Document IPR2018-00943, No. 1040-35 Exhibit - TREXAN, Physicians Desk Reference 936 938 46 ed 1992 (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1019 Exhibit: SJ Heishman et al, Safety And Pharmacokinetics of a New Formulatio...

Document IPR2018-00943, No. 1019-17 Exhibit - SJ Heishman et al, Safety And Pharmacokinetics of a New Formulation of Depot Naltrexone (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1027 Exhibit: Appeal Brief, Application No 13871,534, Oct 19, 2015

Document IPR2018-00943, No. 1027-25 Exhibit - Appeal Brief, Application No 13871,534, Oct 19, 2015 (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1004 Exhibit: US Serial Number 11083,167, Amendment and Response, Oct 5, 200...

Document IPR2018-00943, No. 1004-4 Exhibit - US Serial Number 11083,167, Amendment and Response, Oct 5, 2009 (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1009 Exhibit: US Serial Number 11083,167, Notice of Allowance, Dec 1, 2010

Document IPR2018-00943, No. 1009-9 Exhibit - US Serial Number 11083,167, Notice of Allowance, Dec 1, 2010 (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1042 Exhibit: Orange Book Approved Drug Products with Therapeutic Equivalence...

Document IPR2018-00943, No. 1042-37 Exhibit - Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations (P.T.A.B. Apr. 20, 2018)

cite Cite Document

1031 Exhibit: CV of Dr Park

Document IPR2018-00943, No. 1031-55 Exhibit - CV of Dr Park (P.T.A.B. Apr. 20, 2018)

cite Cite Document
<< 1 2 3 4 5 6 7 8 9 ... >>